RadNet, Inc. logo

RadNet, Inc. (RDNT)

Market Closed
8 Oct, 08:00 PM
XMEX XMEX
MX$
1,231. 34
0
0%
MX$
- Market Cap
930.4 P/E Ratio
- Div Yield
1,000 Volume
0.55 Eps
MX$ 1,231.34
Previous Close
Add Transaction
Day Range
1,231.34 1,231.34
Year Range
919.21 1,315.18
Want to track RDNT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RDNT closed Thursday higher at MX$1,231.34, an increase of 0% from Wednesday's close, completing a monthly decrease of -4.1699% or -MX$53.58. Over the past 12 months, RDNT stock gained 33.9563%.
RDNT is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0.1533%. On average, the company has fell short of earnings expectations by -0.0889%, based on the last three reports.
RadNet, Inc. has completed 1 stock splits, with the recent split occurring on Nov 28, 2006.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).

RDNT Chart

RadNet: Imaging And AI Keep The Bull Case Intact

RadNet: Imaging And AI Keep The Bull Case Intact

RDNT's advanced imaging mix is expanding. I think this will continue to support its improving revenue quality and margins. RDNT's joint ventures across healthcare systems also help it deepen its integration across customers' workflows. DeepHealth is RDNT's second growth leg, as it pairs external software sales with internal workflow efficiencies.

Seekingalpha | 2 months ago
RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised

RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.

Zacks | 2 months ago
RadNet Q2 Earnings Call Highlights

RadNet Q2 Earnings Call Highlights

RadNet NASDAQ: RDNT reported record quarterly revenue and adjusted EBITDA for the second quarter of 2026, supported by higher imaging volumes, acquisitions, a shift toward advanced imaging procedures and growth in its Digital Health segment.

Marketbeat | 2 months ago

RadNet, Inc. (RDNT) FAQ

What is the stock price today?

The current price is MX$1,231.34.

On which exchange is it traded?

RadNet, Inc. is listed on XMEX.

What is its stock symbol?

The ticker symbol is RDNT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has RadNet, Inc. ever had a stock split?

RadNet, Inc. had 1 splits and the recent split was on Nov 28, 2006.

RadNet, Inc. Profile

Professional Services Industry
Industrials Sector
Howard G. Berger CEO
XMEX Exchange
US7504911022 ISIN
US Country
9,060 Employees
- Last Dividend
28 Nov 2006 Last Split
1 Jul 1986 IPO Date

Overview

RadNet, Inc., established in 1981 and headquartered in Los Angeles, California, establishes a prominent position in the United States healthcare infrastructure by providing comprehensive outpatient diagnostic imaging services. The company differentiates its offerings by structuring its operations into two primary segments: Imaging Centers and Artificial Intelligence. This dual-focused approach allows RadNet to cater to the diverse needs of healthcare providers and patients, ensuring both traditional and technologically advanced diagnostic solutions. Through its extensive network and innovative technology deployment, RadNet sets itself apart as a key contributor to the evolving landscape of diagnostic imaging services.

Products and Services

RadNet, Inc. offers a broad spectrum of diagnostic imaging and related services, alongside advanced AI technologies for image interpretation and screening. Below is an elaborated list of its products and services:

  • Magnetic Resonance Imaging (MRI): This service provides detailed images of organs and tissues within the body, utilizing magnetic fields and radio waves. MRI is pivotal for diagnosing a range of conditions, from brain disorders to musculoskeletal injuries.
  • Computed Tomography (CT): CT scans offer cross-sectional images of the body through the use of X-rays and computing algorithms. They are essential in detecting various diseases and conditions, including cancers, heart disease, and internal injuries.
  • Positron Emission Tomography (PET): PET scans, often used in conjunction with CT or MRI scans, provide metabolic and physiological data by detecting radioactive materials injected into the body. This is crucial for cancer diagnosis and monitoring, as well as neurological and cardiac applications.
  • Nuclear Medicine: This involves the use of small amounts of radioactive material to diagnose or treat diseases, including many types of cancers, heart disease, and other abnormalities within the body.
  • Mammography: Specializing in the early detection of breast cancer, mammography utilizes low-dose X-rays to examine breast tissue. This is a critical tool in breast cancer screening and diagnostics.
  • Ultrasound: Using sound waves to produce images of structures within the body, ultrasound services are essential for monitoring pregnancies, diagnosing pelvic and abdominal conditions, and guiding minimally invasive procedures.
  • Diagnostic Radiology: This encompasses a range of imaging modalities, including X-ray, fluoroscopy, and more, to diagnose diseases and conditions across the body.
  • Fluoroscopy: Providing real-time images of the movement of internal fluids, organs, or devices, fluoroscopy is vital for guiding various diagnostic and therapeutic procedures.
  • Multi-Modality Imaging Services: RadNet offers comprehensive imaging solutions that combine multiple diagnostic techniques to provide a holistic view of a patient’s health condition.
  • Computerized Systems for Image Distribution: The company develops advanced systems for the efficient distribution, display, storage, and retrieval of digital images, enhancing the flow of diagnostic information.
  • Picture Archiving Communications Systems (PACS) and Related Services: These systems and services are key to the management of digital imaging and electronic records, improving accessibility and efficiency in healthcare settings.
  • Artificial Intelligence Suites: RadNet develops and deploys AI technologies aimed at enhancing the interpretation of images related to breast, lung, and prostate, alongside providing AI solutions for prostate cancer screening. This technological advancement represents RadNet’s commitment to integrating cutting-edge technology within diagnostic practices.

Contact Information

Address: 1508, 1510 and 1516 Cotner Avenue
Phone: 310 478 7808